Issue 18, 2023

Folic acid–maltodextrin polymer coated magnetic graphene oxide as a NIR-responsive nano-drug delivery system for chemo-photothermal synergistic inhibition of tumor cells

Abstract

The combination of chemo-photothermal therapy with high efficiency and fewer side effects has a good application prospect in cancer treatment. It is of great significance to construct a nano-drug delivery system with cancer cell targeting, high drug loading and excellent photothermal conversion efficiency. Therefore, a novel nano-drug carrier MGO-MDP–FA was successfully constructed by coating folic acid-grafted maltodextrin polymers (MDP–FA) on the surface of Fe3O4-modified graphene oxide (MGO). The nano-drug carrier combined the cancer cell targeting of FA and the magnetic targeting of MGO. A large amount of anti-cancer drug doxorubicin (DOX) was loaded by π–π interaction, hydrogen bond interaction and hydrophobic interaction, with the maximum loading amount and loading capacity of 657.9 mg g−1 and 39.68 wt%, respectively. Based on the excellent photothermal conversion efficiency of MGO, MGO-MDP–FA showed good thermal ablation effect of tumor cells in vitro under NIR irradiation. In addition, MGO-MDP–FA@DOX showed excellent chemo-photothermal synergistic tumor inhibition in vitro (tumor cell killing rate reached 80%). In conclusion, the novel nano-drug delivery system MGO-MDP–FA constructed in this paper provides a promising nano-platform for chemo-photothermal synergistic treatment of cancer.

Graphical abstract: Folic acid–maltodextrin polymer coated magnetic graphene oxide as a NIR-responsive nano-drug delivery system for chemo-photothermal synergistic inhibition of tumor cells

Supplementary files

Article information

Article type
Paper
Submitted
07 Apr 2023
Accepted
15 Apr 2023
First published
24 Apr 2023
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2023,13, 12609-12617

Folic acid–maltodextrin polymer coated magnetic graphene oxide as a NIR-responsive nano-drug delivery system for chemo-photothermal synergistic inhibition of tumor cells

T. Gong, X. Wang, H. Zhu, C. Wen, Q. Ma, X. Li, M. Li, R. Guo and W. Liang, RSC Adv., 2023, 13, 12609 DOI: 10.1039/D3RA02306K

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements